Physician profile
Caitlin E Lopes
NPI 1295267136
$7,225.22
in general payments reported to CMS, 2019-2025
17 companies · $3,206 in 2025
The $3,206 reported for 2025 was more than what 75% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $766 · 2022: $347 · 2023: $442 · 2024: $2,465 · 2025: $3,206.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,109 · Food and Beverage: $1,919 · Education: $85.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,108.75 |
| Food and Beverage | $1,918.67 |
| Education | $85.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,599.87 | 2021-2024 | |
| Janssen Scientific Affairs, LLC | $1,504.56 | 2023-2025 | Erleada, Akeega |
| Janssen Biotech, INC. | $1,269.80 | 2025 | Erleada, Akeega |
| Bayer Healthcare Pharmaceuticals INC. | $897.04 | 2025 | |
| Dendreon Pharmaceuticals LLC | $465.75 | 2021-2023 | Provenge |
| Pfizer INC. | $270.00 | 2024 | |
| Aveo Pharmaceuticals, INC. | $245.11 | 2024 | |
| Incyte Corporation | $235.21 | 2021 | |
| Exelixis INC. | $127.17 | 2023 | Cabometyx |
| Global Blood Therapeutics, INC. | $124.01 | 2021 | |
| Tempus Ai, INC | $123.50 | 2024 | |
| Amgen INC. | $95.00 | 2021 | |
| Astellas Pharma US INC | $85.05 | 2024 | |
| Merck Sharp & Dohme LLC | $82.04 | 2021-2025 | |
| Beigene USA, INC. | $51.97 | 2022-2023 | Brukinsa |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $29.91 | 2023 | Enhertu |
| Seagen INC. | $19.23 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caitlin Lopes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.